| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
paraoxonase 2 | 0.566 | 0.808 | 5.4E-05 |
|
disease | 0.220 | None | 0.667 | 1 | 0 | 2011 | 2019 | ||||||||
|
nuclear receptor subfamily 1 group H member 3 | 0.566 | 0.692 | 0.90 |
|
disease | 0.230 | None | 0.750 | 1 | 0 | 2006 | 2019 | ||||||||
|
neuropeptide Y receptor Y5 | 0.691 | 0.462 | 6.4E-03 |
|
disease | 0.520 | None | 0.750 | 1 | 0 | 1996 | 2007 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
disease | 0.230 | None | 0.750 | 1 | 0 | 2001 | 2018 | ||||||||
|
cystatin C | 0.436 | 0.808 | 3.9E-03 |
|
disease | 0.240 | None | 0.800 | 1 | 0 | 2008 | 2018 | ||||||||
|
insulin like growth factor binding protein 3 | 0.439 | 0.808 | 0.91 |
|
disease | 0.240 | None | 0.800 | 1 | 0 | 2012 | 2017 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.300 | None | 0.833 | 1 | 0 | 2007 | 2019 | ||||||||
|
dopamine receptor D4 | 0.517 | 0.577 | 9.3E-09 |
|
disease | 0.270 | None | 0.875 | 1 | 0 | 1999 | 2015 | ||||||||
|
glucokinase | 0.523 | 0.808 | 0.63 |
|
disease | 0.370 | None | 0.875 | 1 | 0 | 1995 | 2018 | ||||||||
|
cholecystokinin A receptor | 0.615 | 0.500 | 4.0E-03 |
|
disease | 0.270 | None | 0.875 | 1 | 0 | 1997 | 2019 | ||||||||
|
nuclear receptor subfamily 1 group H member 4 | 0.513 | 0.808 | 9.4E-04 |
|
disease | 0.270 | None | 0.875 | 1 | 0 | 1998 | 2019 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.300 | None | 0.882 | 2 | 0 | 2004 | 2020 | ||||||||
|
serpin family F member 1 | 0.460 | 0.846 | 7.8E-08 |
|
disease | 0.290 | None | 0.900 | 1 | 0 | 2008 | 2019 | ||||||||
|
sirtuin 6 | 0.496 | 0.846 | 3.9E-02 |
|
disease | 0.290 | None | 0.900 | 1 | 0 | 2014 | 2019 | ||||||||
|
apelin | 0.497 | 0.769 | 0.46 |
|
disease | 0.300 | None | 0.909 | 1 | 0 | 2005 | 2020 | ||||||||
|
suppressor of cytokine signaling 3 | 0.434 | 0.808 | 0.75 |
|
disease | 0.300 | None | 0.909 | 1 | 0 | 2000 | 2019 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.300 | None | 0.920 | 1 | 0 | 1993 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
disease | 0.300 | None | 0.923 | 1 | 0 | 2007 | 2019 | ||||||||
|
adiponectin receptor 2 | 0.564 | 0.731 | 0.36 |
|
disease | 0.300 | None | 0.929 | 1 | 0 | 2006 | 2019 | ||||||||
|
leptin receptor | 0.433 | 0.808 | 0.99 |
|
disease | 0.700 | None | 0.930 | 4 | 0 | 1966 | 2019 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.600 | None | 0.933 | 2 | 0 | 1998 | 2020 | ||||||||
|
patatin like phospholipase domain containing 3 | 0.556 | 0.692 | 5.7E-08 |
|
disease | 0.400 | None | 0.933 | 1 | 0 | 2001 | 2019 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
disease | 0.300 | None | 0.935 | 1 | 0 | 1992 | 2019 | ||||||||
|
agouti related neuropeptide | 0.488 | 0.769 | 7.0E-04 |
|
disease | 0.700 | None | 0.938 | 1 | 0 | 1997 | 2019 | ||||||||
|
neuropeptide Y receptor Y2 | 0.612 | 0.577 | 3.6E-02 |
|
disease | 0.300 | None | 0.938 | 1 | 0 | 2004 | 2019 |